Insulet (NASDAQ:PODD): Q2 GAAP EPS of $0.02 misses by $0.01.
Revenue of $177.14M (+42.6% Y/Y) beats by $13.51M.
Monday, August 5, 2019
Acceleron Pharma EPS misses by $0.11, misses on revenue
Acceleron Pharma (NASDAQ:XLRN): Q2 GAAP EPS of -$0.34 misses by $0.11.
Revenue of $27.67M (+649.9% Y/Y) misses by $1.05M.
Revance Therapeutics EPS beats by $0.04
Revance Therapeutics (NASDAQ:RVNC): Q2 GAAP EPS of -$0.86 beats by $0.04.
Cash and equivalents of $90.03M
ChemoCentryx, Inc. EPS misses by $0.04, misses on revenue
ChemoCentryx, Inc. (NASDAQ:CCXI): Q2 GAAP EPS of -$0.26 misses by $0.04.
Revenue of $7.17M (-52.3% Y/Y) misses by $2.66M.
Shares -2.76%.
GenMark Diagnostics EPS misses by $0.03, beats on revenue
GenMark Diagnostics (NASDAQ:GNMK): Q2 GAAP EPS of -$0.23 misses by $0.03.
Revenue of $18.37M (+23.0% Y/Y) beats by $0.46M.
Health Insurance Innovations up 4% after hours on Q2 EPS beat, guidance raise
Health Insurance Innovations (NASDAQ:HIIQ) Q2 results: Revenue: $58.4M (-18.7%); net income: $2.3M (+27.1%); non-GAAP net income: $9.9M (+11.7%); non-GAAP EBITDA: $13.8M (+11.1%): EPS: $0.20 (+42.9%); non-GAAP EPS: $0.71 (+34.0%).
Cash flow ops (6 mo.): ($9.0M) (-55.5%).
2019 guidance: Revenue: $450M – 460M from $430M – 440M; non-GAAP EPS: $4.00 – 4.25 from $3.80 – 4.05; non-GAAP EBITDA: $82M – 87M from $72M – 77M.
Shares up 4% after hours.
Previously: Health Insurance Innovations EPS beats by $0.31, misses on revenue (Aug. 5)
Brookdale Senior Living EPS misses by $0.06, beats on revenue
Brookdale Senior Living (NYSE:BKD): Q2 GAAP EPS of -$0.30 misses by $0.06.
Revenue of $1.02B (-12.1% Y/Y) beats by $10M.
Subscribe to:
Posts (Atom)